Digital Therapeutics Market Forecasts to 2030 – Global Analysis By Type (Disease Management and Treatment DTx, Disease Prevention DTx), Service Type (Solutions/Software, Device, Service and Hardware), Purchase Mode (Individual and Group Purchase Organizat

Digital Therapeutics Market Forecasts to 2030 – Global Analysis By Type (Disease Management and Treatment DTx, Disease Prevention DTx), Service Type (Solutions/Software, Device, Service and Hardware), Purchase Mode (Individual and Group Purchase Organization), Sales Channel (Business-to-Consumer (B2C) and Business-to-Business (B2B)), End User and By Geography

According to Stratistics MRC, the Global Digital Therapeutics Market is accounted for $6.68 billion in 2023 and is expected to reach $25.24 billion by 2030 growing at a CAGR of 20.9% during the forecast period. In order to treat, manage, and prevent a wide range of diseases and disorders, digital therapeutics (DTx) delivers medical interventions directly to patients using evidence-based, clinically evaluated software and devices. Digital therapeutics, for instance, can assist patients in managing their symptoms on their own, enhancing their quality of life and other clinical endpoints. By offering therapeutics through smartphones, mobile devices, and comparable modalities, these digital modalities help to reduce the gaps in healthcare.

According to the International Diabetes Federation, globally, the number of people with diabetes aged 20–79 reached 537 million in 2021 from 425 million in 2017. This number is further estimated to reach 643 million by 2030.

Market Dynamics

Driver

Growing incidence of preventable chronic diseases

The high prevalence and incidence rate of chronic diseases is a major concern for healthcare systems across the globe. The treatment of patients with chronic diseases is a significant challenge, as psychosomatic or bio psychic factors very often influence these patients. As chronic diseases are often associated with high levels of uncertainty, patients need to change their behavior as part of a new self-care lifestyle. Furthermore, many chronic disorders and conditions are progressive, and their incidence increases with age. As a result, with significant growth in the global geriatric population, chronic disorders are expected to rise further in the coming years.

Restraint

Patient data privacy concerns

In many countries, various health apps are deprived of appropriate approvals, leading to concerns of product & data quality, reliability in treatment decisions, patient privacy, security, and the responsible use of data. Digital therapeutics providers have access to patient information and are forbidden from sharing the information with anyone not involved in treating that patient. However, with the integration of data using digital tools, the patient’s data is at risk of being accessed by any healthcare professional not related to the patient’s treatment program.

Opportunity

Strategic initiatives by manufacturers

Strategic initiatives practice supports companies undertaking the most important growth or expansion projects. While organizations are normally well-geared to manage the day-to-day aspects of business efficiently, major new strategic initiatives tend to be complex projects with multiple workstreams involved. The team helps clients maintain focus on business-as-usual functions by dexterously supporting the unique and complex task flows that accompany Greenfield integration or post-merger integration.

Threat

Reluctance among patients to adopt digital therapeutics

Motivating people to use digital therapeutics and building their confidence is a major threat faced by digital therapeutics providers. While older and underserved populations show maximum susceptibility to diseases and the highest occurrence rates, they are the least likely to use digital therapeutics products due to low technology literacy levels. Furthermore, the limit of how much behavioural change will be observed with digital therapeutics is still undefined.

Covid-19 Impact

The COVID-19 pandemic is anticipated to have a positive effect on the global market for digital therapeutics due to increased awareness of the value of digital health, an increase in the prevalence of mental illness, and a rise in the rate of drug abuse. Additionally, because people were forced to stay at home due to the pandemic, there was a decrease in physical activity, an increase in unhealthy lifestyle choices, and a rise in stress levels, all of which contributed to the prevalence of chronic diseases. As a result, DTx hardware and software are in greater demand all over the world. Additionally, the market is growing as a result of recent regulatory approvals for treatments based on DTX being more relaxed.

The disease management and treatment DTx segment is expected to be the largest during the forecast period

Over the forecast period, it is anticipated that the disease management and treatment DTx segment will hold the largest market share. This is attributed to the rise in chronic disease prevalence, the availability of affordable digital therapeutic solutions for disease management, rising investments in digital therapeutics, and the need to reduce healthcare costs due to the rising economic burden of healthcare costs.

The business-to-business (B2B) segment is expected to have the highest CAGR during the forecast period

The business-to-business (B2B) segment is growing at the highest CAGR in the market. This is attributed to increasing alertness among providers, payers, and employers about the benefits of digital therapeutics and the inclination of pharmaceutical companies to integrate digital therapeutics with their drug products.

Region with largest share

Throughout the forecast period, North America is anticipated to rule the market. The increasing prevalence of patients with chronic illnesses and mental health conditions, such as substance use disorders, is responsible for the dominance of this regional market. Moreover, the introduction of these devices in the region is also anticipated to increase as a result of an increase in collaborations and agreements among the major players to concentrate on the research and development of these products.

Region with highest CAGR

Due to the increased adoption of technologically advanced products and advantageous government policies, the Asia-Pacific market is estimated to witness the highest compound annual growth rate. The need for healthcare IT systems has been growing as they make it possible to manage hospitals' clinical, financial, and administrative aspects effectively. Additionally, it is anticipated that the widespread use of inexpensive mobile devices and the internet will increase demand for these products, spurring regional market expansion.

Key players in the market

Some of the key players profiled in the Digital Therapeutics Market include 2Morrow, Inc, Akili Interactive Labs, Inc., BigHealth , Canary Health Inc., DarioHealth Corp., Dthera Sciences, Fitbit LLC, GAIA AG, HYGIEIA, Limbix Health, Inc. , Livongo Health, Inc., Mango Health Inc., Medtronic Plc., Noom, Inc., Omada Health, Inc., Pear Therapeutics, Inc., Propeller Health (ResMed), Voluntis, Inc. and Welldoc, Inc.

Key Developments

In January 2023, Lupin, a wholly-owned subsidiary of Lupin Limited, announced the launch of its therapeutics solution, LYFE. LYFE is India’s only evidence-based holistic heart care programme that significantly reduces the risk of a heart attack and improves vitals and quality of life for cardiac patients.

In October 2022, Fitbit Health Solutions introduced a partnership with Pretaa that seeks to improve outcomes for Americans and their families affected by substance abuse by introducing health and activity data in Pretaa’s substance abuse recovery app.

In August 2022, Akili Inc., the maker of a video game-like digital therapeutic for children with ADHD, announced the merger with a special-purpose acquisition company Social Capital Suvretta Holdings Corp.

Types Covered
• Disease Management and Treatment DTx
• Disease Prevention DTx

Service Types Covered
• Solutions/Software
• Device
• Service
• Hardware

Purchase Modes Covered
• Individual
• Group Purchase Organization

Sales Channels Covered
• Business-to-Consumer (B2C)
• Business-to-Business (B2B)

End Users Covered
• Preventive
• Treatment/Care-related

Regions Covered
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026 and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements